Compare TOL & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TOL | COO |
|---|---|---|
| Founded | 1967 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Ophthalmic Goods |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.7B | 16.5B |
| IPO Year | 1994 | 1994 |
| Metric | TOL | COO |
|---|---|---|
| Price | $148.10 | $64.29 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 11 |
| Target Price | ★ $164.44 | $90.18 |
| AVG Volume (30 Days) | 1.0M | ★ 1.7M |
| Earning Date | 05-19-2026 | 05-28-2026 |
| Dividend Yield | ★ 0.67% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.19 | 0.66 |
| Revenue | ★ $7,143,258,000.00 | $2,532,800,000.00 |
| Revenue This Year | N/A | $6.66 |
| Revenue Next Year | $6.01 | $5.18 |
| P/E Ratio | ★ $67.76 | $98.31 |
| Revenue Growth | N/A | ★ 18.41 |
| 52 Week Low | $98.14 | $61.78 |
| 52 Week High | $168.36 | $89.83 |
| Indicator | TOL | COO |
|---|---|---|
| Relative Strength Index (RSI) | 58.96 | 24.49 |
| Support Level | $127.83 | $64.19 |
| Resistance Level | $150.45 | $70.01 |
| Average True Range (ATR) | 3.62 | 1.64 |
| MACD | 1.47 | -0.38 |
| Stochastic Oscillator | 71.65 | 7.07 |
Toll Brothers Inc is the luxury homebuilder in the USA, operating in over 60 markets across 24 states. The Fort Washington, Pennsylvania-headquartered homebuilder caters to affluent first-time, move-up, active-adult, and second-homebuyers. Toll Brothers has shifted in recent years to a greater mix of speculative, or "quick move-in" homes. The homebuilder has also expanded its price points, with a greater emphasis on "affordable luxury. Traditional homebuilding accounts for the majority of Toll Brothers' earnings, but the firm also offers ancillary mortgage, title, insurance, and other services.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.